Next Article in Journal
Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY6 Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis
Next Article in Special Issue
Evolution of Cognitive Disorders in Patients with Mild Cognitive Impairment (MCI) After Ischemic Stroke: Secondary Data Analysis from the Improved Health Care in Neurology and Psychiatry—Longer Life (IHCNP) Study
Previous Article in Journal
Mucuna pruriens, a Possible Treatment for Depressive Disorders
Previous Article in Special Issue
Processing Speed and Attentional Shift/Mental Flexibility in Patients with Stroke: A Comprehensive Review on the Trail Making Test in Stroke Studies
 
 
Article

Article Versions Notes

Neurol. Int. 2024, 16(6), 1528-1539; https://doi.org/10.3390/neurolint16060113
Action Date Notes Link
article xml file uploaded 19 November 2024 11:17 CET Original file -
article xml uploaded. 19 November 2024 11:17 CET Update https://www.mdpi.com/2035-8377/16/6/113/xml
article pdf uploaded. 19 November 2024 11:17 CET Version of Record https://www.mdpi.com/2035-8377/16/6/113/pdf
article html file updated 19 November 2024 11:19 CET Original file https://www.mdpi.com/2035-8377/16/6/113/html
Back to TopTop